Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Active not recruiting 2

Sponsor Class

NIH 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Colorectal Neoplasms 88Colonic Neoplasms 30Colonic Polyps 20Adenoma 19Polyps 8Neoplasms 8Colorectal Neoplasms, Hereditary Nonpolyposis 6Adenomatous Polyps 6Disease 5Rectal Neoplasms 4Pain 4Gastrointestinal Neoplasms 4Stomach Neoplasms 2Peptic Ulcer 2Pancreatic Neoplasms 2Liver Cirrhosis 2Intestinal Neoplasms 2Intestinal Diseases 2Inflammatory Bowel Diseases 2Gastritis, Atrophic 2Digestive System Diseases 2Colitis, Ulcerative 2Anus Neoplasms 2Adenomatous Polyposis Coli 2Turcot syndrome 1Tuberculosis 1Triple Negative Breast Neoplasms 1Signs and Symptoms, Digestive 1Recurrence 1Rectal Diseases 1

Interventions

Fluorouracil 26Radiotherapy 18Mitomycin 17Cisplatin 12Capecitabine 12pembrolizumab 10Magnetic Resonance Spectroscopy 9Cyclophosphamide 9Radiation 8Paclitaxel 8Biopsy 8fludarabine 7Specimen Handling 7Nivolumab 7Drug Therapy 7Carboplatin 7Surveys and Questionnaires 6Cetuximab 6Papillomavirus Vaccines 5dehydroftorafur 4aldesleukin 4Vaccines 4Radiotherapy, Intensity-Modulated 4Observation 4Irinotecan 4Watchful Waiting 3Taxes 3Oxaliplatin 3Light Coagulation 3Ipilimumab 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Anus Neoplasms × Colonoscopy × Clear all
NCT03233711 2026-05-13

Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer

National Cancer Institute (NCI)

Phase 3 Active not recruiting
344 enrolled
Gastrointestinal

Anal Canal Carcinoma, Anus Neoplasms

NCT04929028 2026-05-13

Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer

National Cancer Institute (NCI)

Phase 2 Active not recruiting
40 enrolled
Gastrointestinal

Anus Neoplasms, Rectal Neoplasms, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡